Page last updated: 2024-08-21

c.i. 42510 and Brain Neoplasms

c.i. 42510 has been researched along with Brain Neoplasms in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19902 (20.00)18.7374
1990's1 (10.00)18.2507
2000's2 (20.00)29.6817
2010's4 (40.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
Drummond, KJ; Kan, LK; Monif, M; O'Brien, TJ; Seneviratne, S; Williams, DA1
Li, A; Liu, T; Xin, Y; Xu, Y1
Chen, T; Huang, DL; Kopelman, R; Orringer, DA; Philbert, M; Sagher, O1
Jantaratnotai, N; McGeer, PL; McLarnon, JG; Ryu, JK; Serrano-Perez, MC1
Chen, T; Fotiadis, P; Gao, D; Hah, HJ; Kim, G; Kochi, A; Kopelman, R; Lee, YE; Miller, A; Nie, G; Orringer, DA; Philbert, MA; Qin, M; Ratani, TS; Sagher, O1
Ames, HM; Benes, FM; Cunningham, MG; Donalds, RA1
Camby, I; Danguy, A; Kiss, R; Pasteels, JL; Salmon, I1
Angelova, A; Chakalova, L; Chakarov, S; Ganev, V; Tencheva, Z1
Bojinov, S; Ivanova, A; Lolova, I1
Connor, RC1

Other Studies

10 other study(ies) available for c.i. 42510 and Brain Neoplasms

ArticleYear
P2X7 receptor antagonism inhibits tumour growth in human high-grade gliomas.
    Purinergic signalling, 2020, Volume: 16, Issue:3

    Topics: Adamantane; Aminoquinolines; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Glioma; Humans; Microglia; Microscopy, Confocal; Purinergic P2X Receptor Antagonists; Receptors, Purinergic P2X7; Rosaniline Dyes; Signal Transduction; Tumor Microenvironment

2020
MCCK1 enhances the anticancer effect of temozolomide in attenuating the invasion, migration and epithelial-mesenchymal transition of glioblastoma cells in vitro and in vivo.
    Cancer medicine, 2019, Volume: 8, Issue:2

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Synergism; Epithelial-Mesenchymal Transition; Female; Glioblastoma; Humans; Mice, Inbred BALB C; Mice, Nude; Rosaniline Dyes; Temozolomide

2019
A technical description of the brain tumor window model: an in vivo model for the evaluation of intraoperative contrast agents.
    Acta neurochirurgica. Supplement, 2011, Volume: 109

    Topics: Animals; Brain Mapping; Brain Neoplasms; Cell Line, Tumor; Contrast Media; Disease Models, Animal; Disease Progression; Glioma; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Monitoring, Intraoperative; Rats; Rats, Sprague-Dawley; Rosaniline Dyes

2011
Block of purinergic P2X7R inhibits tumor growth in a C6 glioma brain tumor animal model.
    Journal of neuropathology and experimental neurology, 2011, Volume: 70, Issue:1

    Topics: Aged; Animals; Brain Neoplasms; Disease Models, Animal; Drug Delivery Systems; Gene Expression Regulation; Glioma; Growth Inhibitors; Humans; Male; Middle Aged; Purinergic P2X Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2X7; Rosaniline Dyes; Tumor Cells, Cultured

2011
Hydrogel nanoparticles with covalently linked coomassie blue for brain tumor delineation visible to the surgeon.
    Small (Weinheim an der Bergstrasse, Germany), 2012, Mar-26, Volume: 8, Issue:6

    Topics: Brain Neoplasms; General Surgery; Humans; Hydrogels; Magnetic Resonance Spectroscopy; Mass Spectrometry; Nanoparticles; Rosaniline Dyes; Tumor Cells, Cultured; Workforce

2012
Construction and implantation of a microinfusion system for sustained delivery of neuroactive agents.
    Journal of neuroscience methods, 2008, Jan-30, Volume: 167, Issue:2

    Topics: Animals; Brain; Brain Neoplasms; Catheterization; Glial Fibrillary Acidic Protein; Infusion Pumps; Infusion Pumps, Implantable; Male; Rats; Rats, Sprague-Dawley; Rosaniline Dyes; Time Factors

2008
Computer-assisted microscope characterization of BCNU-induced modifications in the collective behavior of 12 human brain cancer cell lines.
    Journal of neuro-oncology, 1996, Volume: 28, Issue:1

    Topics: Brain Neoplasms; Carcinogens; Carmustine; Cell Count; Cell Death; Cell Division; Cell Survival; Coloring Agents; DNA, Neoplasm; Glioma; Humans; Image Processing, Computer-Assisted; Mathematics; Ploidies; Rosaniline Dyes; Tumor Cells, Cultured

1996
Morphine treatment affects the regulation of high mobility group I-type chromosomal phosphoproteins in C6 glioma cells.
    Life sciences, 2000, Mar-24, Volume: 66, Issue:18

    Topics: Analgesics, Opioid; Animals; Autoradiography; Blotting, Northern; Brain Neoplasms; Chromosomes; Electrophoresis, Polyacrylamide Gel; Glioma; High Mobility Group Proteins; HMGA1a Protein; Morphine; Rats; Rosaniline Dyes; Transcription Factors

2000
Histochemical investigation of nonspecific acid phosphatase in cerebral tumors.
    Journal of neurosurgery, 1971, Volume: 34, Issue:6

    Topics: Acid Phosphatase; Adenoma, Chromophobe; Astrocytoma; Biopsy; Brain Neoplasms; Choroid Plexus; Ependymoma; Glioblastoma; Hemangiosarcoma; Histocytochemistry; Humans; Medulloblastoma; Meningioma; Neurilemmoma; Oligodendroglioma; Papilloma; Pituitary Neoplasms; Rosaniline Dyes; Sarcoma; Staining and Labeling

1971
Fuchsinophilic degeneration of myocardium in patients with intracranial lesions.
    British heart journal, 1970, Volume: 32, Issue:1

    Topics: Adolescent; Adult; Aged; Brain Neoplasms; Cardiomyopathies; Catecholamines; Cerebrovascular Disorders; Coronary Disease; Craniocerebral Trauma; Encephalitis; Female; Heart Transplantation; Hemorrhage; Humans; Male; Middle Aged; Pulmonary Edema; Rosaniline Dyes; Sympathetic Nervous System; Transplantation, Homologous

1970